Jean-Gabriel Griboul

Associé

Paris + 33.1.56.59.38.92

Contact

Partager

Jean-Gabriel Griboul intervient depuis 20 ans dans les domaines du private equity, des fusions-acquisitions et du droit boursier.

Il assiste des sociétés de croissance cotées et non cotées et leurs actionnaires dirigeants, financiers ou industriels, à tous les stades de leur développement, depuis leur création jusqu'à leur introduction en bourse et, au-delà, dans leur vie de sociétés cotées, ainsi que de grands groupes industriels français et internationaux.

A ce titre, il conduit chaque année un grand nombre d'opérations de capital-risque et de capital développement, de fusions-acquisitions, d'introduction en bourse, d'offres publiques et de placements privés, à titre principal dans les secteurs du logiciel, des biotech/medtech, de la fintech et de la transition énergétique.

Les opérations récentes menées par Jean-Gabriel Griboul comprennent notamment:

M&A : l’acquisition par Taranis Investments (groupe Perenco) des projets éoliens et photovoltaïques Africains du groupe Akuo; toutes les opérations M&A de Swile, notamment l'acquistion de Bimpli ; les opérations de croissance externe de Doctolib ;

PE : l’investissement de Sanofi dans une nouvelle société de biotechnologies contrôlée par Orano Med ; toutes les levées de fonds de Swile ; le financement par ADEME Investissement des activités de développement des projets d'éolien en mer flottant de BW Ideol ; les tours de financement d’Unseenlabs ;

Droit boursier : l'introduction en bourse de Nanobiotix sur le Nasdaq ; l'offre publique d'achat de ChapsVision sur Coheris.

Expérience

  • Taranis Investment Limited, a Perenco group company, acquires Africa business of the Akuo GroupJones Day advised Taranis Investment Limited, a Perenco group company, in the acquisition of the African project portfolio from Akuo Energy Afrique, a renewable energy developer.
  • Ankaa Ventures leads Sepia Infrastructure first fundraisingJones Day advised Ankaa Ventures as a lead investor in the first fundraising for Sepia Infrastructure, a data center land and power provider that develops low-carbon energy solutions for the European industrial technology market.
  • Swile and Groupe BPCE to combine to create global leader in employee benefitsJones Day advised Swile, a worktech unicorn, in the acquisition of Bimpli, a subsidiary of Groupe BPCE and leader in employee services and benefits in France.
  • Tikehau Capital, Wendel Growth, Definvest (Bpifrance), and 360 Capital sell their stakes in Preligens to SafranJones Day advised Tikehau Capital, Wendel Growth, Definvest (Bpifrance), and 360 Capital in the sale of their stakes in Preligens, a world leader in artificial intelligence (AI) for aerospace and defense, to Safran.
  • Doctolib acquires Aaron.aiJones Day advised Doctolib, the leading healthtech company in Europe, in its acquisition of the Berlin company Aaron.ai, the current market leader in Germany for AI-based telephone assistance solutions for medical practices, relieving doctors and practice staff of answering telephone calls and offering patients telephone access to doctors' practices around the clock.
  • Unseenlabs raises €85 millionJones Day advised Unseenlabs, a France-based company and global leader in maritime surveillance through detection and geolocation of radio frequency signals from space, in its €85 million financing for significant expansion of observation capabilities, strengthening of international presence, consolidation of private sector activities, innovation of new products and solutions, and recruitment of new talents.
  • Quandela raises €50 millionJones Day advised Quandela, the European leader in photonic quantum computing, in raising €50 million from investors, the French government through the France 2030 Plan, and banking partners, allowing Quandela to expedite its international expansion and increase the production of its quantum computers to meet the needs of industrial clients.
  • Euroclear invests in IZNESJones Day advised Euroclear in its investment in IZNES, a pan-European funds marketplace based on blockchain technology.
  • Swile raises $200 million in Series D financingJones Day advised Swile, a French-based tech company that offers digital solutions for employee rewards and benefits through a custom card and app, in connection with its $200 million Series D round of financing led by SoftBank, alongside existing investors Index Ventures, Eurazeo and Bpifrance Large Venture.
  • Vibe.co raises $22.5 million in Series A fundingJones Day advised Vibe.co, an operator of a programmatic advertising space buying platform that enables brands to broadcast and run their own advertising campaigns on connected TVs and other applications that deliver video content, in its $22.5 million Series A funding led by Singular.
  • Elaia Partners and Opera Tech Ventures (OTV) invest in €35 million Series B2 funding of SESAMmJones Day advised Elaia Partners and Opera Tech Ventures (OTV- the Venture Arm of BNP Paribas) in their co-lead of the €35 million Series B2 funding of SESAMm, a leader in natural language processing (NLP), a field of artificial intelligence.
  • Adikteev bought out by managementJones Day advised Adikteev SA in the management buyout by Xavier Mariani and Emilien Eychenne as well as several other executives.
  • Debiopharm and M Ventures co-lead €15.5 million Series A financing of IktosJones Day advised Debiopharm Innovation Fund, M Ventures, and Omnes Capital in the €15.5 million Series A financing of Iktos, a company specializing in artificial intelligence for new drug discovery.
  • Illuminate Financial participates in $16 million Series A financing of GladiaJones Day advised Illuminate Financial in connection with its participation in the $16 million Series A financing of Gladia, a French AI software provider dedicated to artificial intelligence.
  • Portage and Orange Ventures lead €37 million Series C financing of MooncardJones Day advised Portage and Orange Ventures as lead investors in connection with the €37 million Series C financing of Mooncard, the French leader in the automation of corporate spend, in which historical investors Aglaé Ventures, BlackFin Capital Partners, Partech Partners and RAISE Ventures also participated.
  • Elaia Partners, XAnge, and Bpifrance participate in €27 million Series B financing of GleamerJones Day advised Elaia Partners, XAnge, and Bpifrance in connection with the €27 million Series B financing of Gleamer, the leading European manufacturer in AI-powered solutions for medical imaging.
  • Portage Ventures (Sagard) participates in €29 million funding round of AcheelJones Day represented Portage Ventures (Sagard) in the €29 million funding round of Acheel, a Paris, France based startup building a digital platform for selling non-life insurance products.
  • Nanobiotix completes $113.3 million IPO on NasdaqJones Day represented Nanobiotix S.A., a French clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, in connection with its $113.3 million initial public offering in the United States and listing on Nasdaq.
  • Snapshift raises $45 million in Series A roundJones Day advised Snapshift, the French SaaS HR application for businesses in the hospitality and retail sector, in its $45 million Series A financing round led by Highland Europe.
  • Elaia Partners and Hi Inov sell ForePaaS to OVHcloudJones Day advised Elaia Partners and Hi Inov in the sale of ForePaaS, a unified platform specializing in data analytics, machine learnings, and artificial intelligence projects for businesses, to OVHcloud, the European leader in cloud computing.
    •

    November 2018 Commentary

    Driverless, Networked Vehicles on the Rise, French Liability Regulations Lag Behind

    September 18-20, 2023 Speaking Engagements

    Jones Day lawyers to attend IPEM 2023

    • 12 avril 2018
      Finale de la 4ème édition du Prix Jones Day/Paris II/ESSEC
    • 7 janvier 2016
      Le private equity : quelles opportunités pour 2016 ?

    Avant d’envoyer cet e-mail, veuillez prendre note de ce qui suit :

    Les informations contenues sur le site www.jonesday.com sont destinées à un usage général et ne constituent pas des conseils juridiques. L’envoi et la réception de cet e-mail n’ont pas pour effet de créer une relation avocat-client. Aucun envoi de votre part à un membre du Cabinet ne sera traité comme confidentiel ou protégé à moins que nous n’ayons donné notre accord pour vous représenter. En envoyant cet e-mail, vous confirmez avoir lu et compris la présente notification.